Table 1 |
||||||
|
Design aspects and odds ratios (ORs) (crudes and corrected for self-selection bias) of six case-control studies. |
||||||
|
Paper |
Country |
Time period of breast cancer deaths |
Cases (n) |
Screening exposure |
Crude Ors (95% CI) |
ORs adjusted for self-selection bias |
|
|
||||||
|
Allgood et al. [15] |
UK |
1995-2004 |
284 |
Ever/Never attendance before (pseudo) diagnosis |
0.35 (0.24-0.51) |
0.52 (0.32-0.84) |
|
Fielder et al. [16] |
Wales |
1998-2001 |
419 |
Ever/Never attendance before (pseudo) diagnosis |
0.62 (0.47-0.82) |
0.75 (0.49-1.14) |
|
Gabe et al. [17] |
Iceland |
1990-2002 |
226 |
Ever/Never attendance before (pseudo) diagnosis |
0.59 (0.41-0.84) |
0.65 (0.39-1.09) |
|
Paap et al. [18] |
Netherlands |
2004-2005 |
118 |
Screened at index invitation |
0.30 (0.14-0.63) |
0.24 (0.10-0.58) |
|
Puliti et al. [19] |
Italy |
1988-2002 |
1750 |
Ever/Never attendance before (pseudo) diagnosis |
0.46 (0.38-0.56) |
0.55 (0.36-0.85) |
|
Roder et al. [20] |
Australia |
2002-2005 |
491 |
Ever/Never attendance before (pseudo) diagnosis |
0.59 (0.47-0.74) |
0.70a |
|
|
||||||
|
Source: Paap et al., 2010 [11] modified. aValues of confidence interval not reported in the paper. |
||||||
|
Puliti and Zappa BMC Medicine 2012 10:106 doi:10.1186/1741-7015-10-106 |
||||||
